These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6352025)
61. [Myocardial infarct: secondary prevention with drugs and their effects]. Kanazawa T; Matsuoka H Nihon Rinsho; 1980 Oct; 38(10):4097-105. PubMed ID: 7019479 [No Abstract] [Full Text] [Related]
62. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease. Rowe GG; Folts JD Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246 [TBL] [Abstract][Full Text] [Related]
64. Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction. Spann JF Am J Med; 1983 May; 74(5):877-86. PubMed ID: 6132553 [TBL] [Abstract][Full Text] [Related]
65. Antithrombotic drugs in relation to prostaglandin metabolism. O'Grady J; Bunting S; Moncada S Clin Haematol; 1980 Oct; 9(3):535-55. PubMed ID: 7004686 [No Abstract] [Full Text] [Related]
66. [The use of drugs that affect thrombocytes in cerebral ischemia]. Kaste M; Fogelholm R Duodecim; 1990; 106(11):855-7. PubMed ID: 1670321 [No Abstract] [Full Text] [Related]
67. Aspirin in the treatment of cardiovascular disease: a review. Mustard JF; Kinlough-Rathbone RL; Packham MA Am J Med; 1983 Jun; 74(6A):43-9. PubMed ID: 6407310 [TBL] [Abstract][Full Text] [Related]
68. Presentation and analysis of the results of clinical trials in cardiovascular disease. Hampton JR Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1371-3. PubMed ID: 6786503 [No Abstract] [Full Text] [Related]
69. Clinical application of platelet inhibitors in vascular diseases. Fields WS Med Res Rev; 1982; 2(4):395-401. PubMed ID: 6757596 [No Abstract] [Full Text] [Related]
70. Antiplatelet agents and diabetic vascular disease. Colwell JA Trans Am Clin Climatol Assoc; 1987; 98():119-27. PubMed ID: 3303615 [No Abstract] [Full Text] [Related]
71. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Colwell JA; Bingham SF Haemostasis; 1986; 16(6):433-8. PubMed ID: 3556347 [TBL] [Abstract][Full Text] [Related]
72. Issues in planning and interpreting active control equivalence studies. Makuch R; Johnson M J Clin Epidemiol; 1989; 42(6):503-11. PubMed ID: 2661729 [TBL] [Abstract][Full Text] [Related]
73. Aspirin in myocardial ischemia: why, when, and how much? Mehta JL; Conti CR Clin Cardiol; 1989 Apr; 12(4):179-84. PubMed ID: 2653681 [No Abstract] [Full Text] [Related]